Thomas Seoh, CEO of Kinexum
Thomas Seoh is an entrepreneur and executive who has held senior leadership positions in public and private, pharmaceutical, biotech and medical device companies for over 25 years.
After practicing corporate law in New York and London and serving as General Counsel for the North American holding company for Australian billionaire Kerry Packer, he held legal management positions in the ICN Pharmaceuticals group of companies in Costa Mesa, which developed the antiviral, VIRAZOLE®. He next joined Guilford Pharmaceuticals in Baltimore, which commercialized GLIADEL® wafer for glioblastoma multiforme and developed the propofol pro-drug LUSEDRA®, first as VP, General Counsel and Secretary, and later as SVP Corporate and Commercial Development. He was then CEO of venture-backed Faust Pharmaceuticals in Strasbourg, France, developing drug candidates for Parkinson’s disease and Duchenne muscular dystrophy patients. He additionally served on the board or leadership teams of medical device companies working on ex vivo liver dialysis, mechanical thrombectomy and a skin substitute. He joined Kinexum as CEO in 2017.
Thomas holds an AB in Philosophy and History and a JD from Harvard University.